Drugplain

Ebanga 400 mg/8mL

Ansuvimab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Emergent Manufacturing Operations Baltimore, LLC

No Recall History
Plain English

Ebanga is a injection, powder, lyophilized, for solution containing ansuvimab at 400 mg/8mL, taken intravenous. Manufactured by Emergent Manufacturing Operations Baltimore, LLC.

Key Facts

Brand Name
Ebanga
Generic Name
Ansuvimab
NDC Code (Product)
71655-578
Manufacturer
Emergent Manufacturing Operations Baltimore, LLC
Strength
400 mg/8mL
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
BLA761172
Drug Class
Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]
Marketing Start
12/21/2020

Recall History

No Recall History

Frequently Asked Questions

What is Ebanga used for?

Ebanga contains Ansuvimab. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.

Is Ebanga a controlled substance?

Ebanga is not classified as a controlled substance by the DEA.

What is the generic name for Ebanga?

The generic name for Ebanga is Ansuvimab. There are 1 other brand versions of Ansuvimab.

What is the NDC code for Ebanga 400 mg/8mL?

The NDC (National Drug Code) for Ebanga 400 mg/8mL is 71655-578, listed by Emergent Manufacturing Operations Baltimore, LLC.

Product NDC

71655-578

Package NDC

71655-578-03

Other Ansuvimab Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)